DENTSPLY SIRONA Inc. Files 8-K on Officer/Director Changes

Ticker: XRAY · Form: 8-K · Filed: Oct 3, 2025 · CIK: 818479

Dentsply Sirona Inc. 8-K Filing Summary
FieldDetail
CompanyDentsply Sirona Inc. (XRAY)
Form Type8-K
Filed DateOct 3, 2025
Risk Levelmedium
Pages3
Reading Time3 min
Key Dollar Amounts$0.01, $30,000, $20,000
Sentimentneutral

Sentiment: neutral

Topics: officer-changes, director-changes, compensation

Related Tickers: XRAY

TL;DR

DENTSPLY SIRONA Inc. (XRAY) filed an 8-K detailing changes in directors/officers and compensation.

AI Summary

DENTSPLY SIRONA Inc. filed an 8-K on October 3, 2025, reporting events as of October 2, 2025. The filing primarily concerns the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.

Why It Matters

This filing indicates potential shifts in leadership or executive compensation at DENTSPLY SIRONA Inc., which could impact the company's strategic direction and investor confidence.

Risk Assessment

Risk Level: medium — Changes in directors and officers, especially if related to performance or compensation, can signal underlying issues or strategic shifts that may affect the company's future performance.

Key Players & Entities

  • DENTSPLY SIRONA Inc. (company) — Registrant
  • October 2, 2025 (date) — Date of earliest event reported
  • October 3, 2025 (date) — Date of report

FAQ

What specific officers or directors have departed from DENTSPLY SIRONA Inc. as of October 2, 2025?

The filing indicates the 'Departure of Directors or Certain Officers' as an item of information, but does not list specific names in the provided text.

Who has been elected as a new director to the board of DENTSPLY SIRONA Inc.?

The filing lists 'Election of Directors' as an item of information, but the specific names of newly elected directors are not detailed in the provided text.

Were there any new appointments of certain officers at DENTSPLY SIRONA Inc. on or before October 2, 2025?

The filing confirms 'Appointment of Certain Officers' as a reported item, but the specific individuals appointed are not named in the excerpt.

What are the details of the compensatory arrangements for certain officers at DENTSPLY SIRONA Inc.?

The filing includes 'Compensatory Arrangements of Certain Officers' as a reported item, but the specifics of these arrangements are not provided in the given text.

What financial statements or exhibits are included with this 8-K filing?

The filing states that 'Financial Statements and Exhibits' are included, but the specific contents are not detailed in the provided text.

Filing Stats: 776 words · 3 min read · ~3 pages · Grade level 12.1 · Accepted 2025-10-03 16:19:08

Key Financial Figures

  • $0.01 — ich registered Common Stock, par value $0.01 per share XRAY The Nasdaq Stock Market
  • $30,000 — eig will receive a monthly fixed fee of $30,000 for his services as Special Legal Advis
  • $20,000 — pay Mr. Rosenzweig a consulting fee of $20,000 a month. Mr. Rosenzweig's receipt of su

Filing Documents

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 10.1 Transition, Separation and Release of Claims Agreement by and between DENTSPLY SIRONA Inc. and Richard C. Rosenzweig, dated October 2, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DENTSPLY SIRONA Inc. By: /s/ Daniel T. Scavilla Daniel T. Scavilla President and Chief Executive Officer Date: October 3, 2025

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.